Ug Investment Advisers Ltd. Hutchmed (China) LTD Transaction History

Ug Investment Advisers Ltd.

  • $266 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023
SELL
$7.65 - $15.51 $267,750 - $542,850
-35,000 Reduced 72.68%
13,155 $194 Million
Q3 2021

Nov 08, 2021
BUY
$35.66 - $42.94 $534,900 - $644,100
15,000 Added 45.24%
48,155 $1.76 Million
Q2 2021

Aug 10, 2021
BUY
$23.7 - $39.27 $785,773 - $1.3 Million
33,155 New
33,155 $1.3 Million

Others Institutions Holding HCM

# of Institutions
65
Shares Held
6.88M
Call Options Held
6.2K
Put Options Held
1.1K
View Full List

About HUTCHMED (China) Ltd

HCM Quotes by TradingView
  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $2.9B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Ug Investment Advisers Ltd. Portfolio

Follow Ug Investment Advisers Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ug Investment Advisers Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Ug Investment Advisers Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email